Acta Dermato Venereologica · 2010 · 10 citations · 9 references
MedicineDermatologyPathologyCutaneous OncologyDermatopathologyImmunopathologyCutaneous LymphomaCutaneous NeoplasmsImmunopathology Of SkinInfectious DermatosesNeoplastic Skin LesionsPruritic Skin DiseaseAdult T-cell Leukemia-lymphomaCutaneous T-cell Lymphoma ImmunopathologyPruritic DermatitisPruritic Dermatoses
Prurigo nodularis is a pruritic dermatosis of unknown origin. Human T-cell lymphotropic virus type 1 (HTLV-1) causes adult T-cell leukaemia/lymphoma. HTLV-1 is not considered to be a cause of prurigo nodularis. A 52-year-old black man, from the French West Indies, who had had prurigo nodularis for 12 years, presented with a distinct micropapular eruption with the typical pathological picture of epidermotropic T-cell lymphoma. Based on HTLV-1-positive serology and monoclonal integration of HTLV-1 we diagnosed smouldering adult T-cell leukaemia/lymphoma. Re-examination of previous skin biopsies revealed that the disease had been evolving for 12 years. Treatment with alpha-interferon, 3 x 106 units three times a week, associated with zidovudine, 1 g daily, resulted in complete remission within 4 months. When investigating a prurigo nodularis, we therefore recommend: (i) performing HTLV-1 serology if the patient comes from an endemic area; (ii) if positive, performing CD25 staining and looking for a HTLV-1 clonal integration; and (iii) if positive, using a treatment targeting HTLV-1.
9
Nodular prurigo—a clinicopathological study of 46 patients
C M E Rowland Payne, J. D. Wilkinson, Phillip H. McKee et al. · British Journal of Dermatology · 1985 · 140 citations
Medicine, Dermatology, Pathology +13
Thalidomide treatment of prurigo nodularis
R. K. WINKELMANN, S. M. Connolly, J. Stephen Doyle et al. · Acta Dermato Venereologica · 1984 · 67 citations · Full text